These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35955152)

  • 21. Physico-chemical characterization and in vitro dissolution assessment of clonazepam-cyclodextrins inclusion compounds.
    Patel R; Purohit N
    AAPS PharmSciTech; 2009; 10(4):1301-12. PubMed ID: 19885735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Empirical, thermodynamic and quantum-chemical investigations of inclusion complexation between flavanones and (2-hydroxypropyl)-cyclodextrins.
    Liu B; Li W; Nguyen TA; Zhao J
    Food Chem; 2012 Sep; 134(2):926-32. PubMed ID: 23107709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of beta-cyclodextrin complexation on carbamazepine release from hydroxypropyl methylcellulose matrix tablets.
    Koester LS; Xavier CR; Mayorga P; Bassani VL
    Eur J Pharm Biopharm; 2003 Jan; 55(1):85-91. PubMed ID: 12551708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of the complexes of furosemide with 2-hydroxypropyl-beta-cyclodextrin and sulfobutyl ether-7-beta-cyclodextrin.
    Spamer E; Müller DG; Wessels PL; Venter JP
    Eur J Pharm Sci; 2002 Sep; 16(4-5):247-53. PubMed ID: 12208454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of inclusion complexation with cyclodextrins on photostability of nifedipine in solid state.
    Bayomi MA; Abanumay KA; Al-Angary AA
    Int J Pharm; 2002 Aug; 243(1-2):107-17. PubMed ID: 12176299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro and in vivo studies on the complexes of vinpocetine with hydroxypropyl-beta-cyclodextrin.
    Nie S; Fan X; Peng Y; Yang X; Wang C; Pan W
    Arch Pharm Res; 2007 Aug; 30(8):991-1001. PubMed ID: 17879753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation, characterization and in vivo evaluation of formulation of repaglinide with hydroxypropyl-β-cyclodextrin.
    Liu M; Cao W; Sun Y; He Z
    Int J Pharm; 2014 Dec; 477(1-2):159-66. PubMed ID: 25455768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential use of 2-hydroxypropyl-beta-cyclodextrin for preparation of orally disintegrating tablets containing dl-alpha-tocopheryl acetate, an oily drug.
    Motoyama K; Nagatomo K; Abd Elazim SO; Hirayama F; Uekama K; Arima H
    Chem Pharm Bull (Tokyo); 2009 Nov; 57(11):1206-12. PubMed ID: 19881268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of cefpodoxime proxetil release and antimicrobial activity from tablet formulations: complexation with hydroxypropyl-β-cyclodextrin in the presence of water soluble polymer.
    Gundogdu E; Koksal C; Karasulu E
    Drug Dev Ind Pharm; 2012 Jun; 38(6):689-96. PubMed ID: 22010782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The mechanism of bensulfuron-methyl complexation with β-cyclodextrin and 2-hydroxypropyl-β-cyclodextrin and effect on soil adsorption and bio-activity.
    Geng Q; Li T; Wang X; Chu W; Cai M; Xie J; Ni H
    Sci Rep; 2019 Feb; 9(1):1882. PubMed ID: 30760785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formulation and In-vitro Evaluation of Orally Disintegrating Tablets of Olanzapine-2-Hydroxypropyl-β-Cyclodextrin Inclusion Complex.
    Ajit Shankarrao K; Dhairysheel Mahadeo G; Pankaj Balavantrao K
    Iran J Pharm Res; 2010; 9(4):335-47. PubMed ID: 24381598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An investigation into the supramolecular structure, solubility, stability and antioxidant activity of rutin/cyclodextrin inclusion complex.
    Nguyen TA; Liu B; Zhao J; Thomas DS; Hook JM
    Food Chem; 2013 Jan; 136(1):186-92. PubMed ID: 23017411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies.
    Sherje AP; Kulkarni V; Murahari M; Nayak UY; Bhat P; Suvarna V; Dravyakar B
    Mol Pharm; 2017 Apr; 14(4):1231-1242. PubMed ID: 28248111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solubility Enhancement of Myricetin by Inclusion Complexation with Heptakis-
    Han D; Han Z; Liu L; Wang Y; Xin S; Zhang H; Yu Z
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inclusion complexation of lorazepam with different cyclodextrins suitable for parenteral use.
    Holvoet C; Vander Heyden Y; Plaizier-Vercammen J
    Drug Dev Ind Pharm; 2005 Jul; 31(6):567-75. PubMed ID: 16109630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes.
    Patel SG; Rajput SJ
    AAPS PharmSciTech; 2009; 10(2):660-9. PubMed ID: 19459053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hot liquid extrusion assisted drug-cyclodextrin complexation: a novel continuous manufacturing method for solubility and bioavailability enhancement of drugs.
    Manne ASN; Hegde AR; Raut SY; Rao RR; Kulkarni VI; Mutalik S
    Drug Deliv Transl Res; 2021 Jun; 11(3):1273-1287. PubMed ID: 32959332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In Vitro and Ex Vivo Evaluation of Tablets Containing Piroxicam-Cyclodextrin Complexes for Buccal Delivery.
    Kontogiannidou E; Ferrari M; Deligianni AD; Bouropoulos N; Andreadis DA; Sorrenti M; Catenacci L; Nazari K; Arshad MS; Chang MW; Ahmad Z; Fatouros DG
    Pharmaceutics; 2019 Aug; 11(8):. PubMed ID: 31398833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and characterization of hydroxypropyl-β-cyclodextrin inclusion complex of eugenol: differential pulse voltammetry and (1)H-NMR.
    Garg A; Gupta B; Prakash R; Singh S
    Chem Pharm Bull (Tokyo); 2010 Oct; 58(10):1313-9. PubMed ID: 20930396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-hyperalgesic and anti-inflammatory effects of citral with β-cyclodextrin and hydroxypropyl-β-cyclodextrin inclusion complexes in animal models.
    Campos CA; Lima BS; Trindade GGG; Souza EPBSS; Mota DSA; Heimfarth L; Quintans JSS; Quintans-Júnior LJ; Sussuchi EM; Sarmento VHV; Carvalho FMS; Marreto RN; Costa RMR; Nunes RS; Araújo AAS; Shanmugam S; Thangaraj P
    Life Sci; 2019 Jul; 229():139-148. PubMed ID: 31085246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.